Adage Capital Partners
ORKA

Adage Capital Partners’s Oruka Therapeutics ORKA Stock Holding History

Adage Capital Partners’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.8M Buy
355,003
+164,973
+87% +$11M 0.05% 362
2026
Q1 		$9.32M Buy
+190,030
New +$6.6M 0.01% 703
2025
Q1 		– Sell
-69,200
Closed -$1.34M – 963
2024
Q4 		$1.34M Sell
69,200
-130,800
-65% -$3.19M ﹤0.01% 808
2024
Q3 		$4.9M Buy
200,000
+100,000
+100% +$3.48M 0.01% 716
2024
Q2 		$4.6M Buy
+100,000
New +$3.99M 0.01% 720

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Adage Capital Partners's ORKA Position: Q2 2026 in Review

Adage Capital Partners increased its Oruka Therapeutics (ORKA) stake by 87% in Q2 2026, buying an estimated $11M and bringing the position to 355,003 shares worth $33.8M. The position accounts for 0.05% of the portfolio, ranked #362.

Adage Capital Partners first reported a position in ORKA in Q2 2024 and has held it in 5 quarters since. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Adage Capital Partners held 355,003 shares of Oruka Therapeutics worth $33.8M as of Q2 2026.
  • Adage Capital Partners bought 164,973 Oruka Therapeutics shares in Q2 2026, an estimated $11M.
  • Oruka Therapeutics made up 0.05% of Adage Capital Partners's portfolio in Q2 2026, its #362 holding.
  • Adage Capital Partners first reported a position in Oruka Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • 256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.